CONTEXT: Rural persons with human immunodeficiency virus (HIV) face many barriers to care, but little is known about rural-urban variation in HIV outcomes. OBJECTIVE: To determine the association between rural residence and HIV outcomes. DESIGN, SETTING, AND PATIENTS: Retrospective cohort study of mortality among persons initiating HIV care in Veterans Administration (VA) during 1998-2006, with mortality follow-up through 2008. Rural residence was determined using Rural Urban Commuting Area codes. We identified 8489 persons initiating HIV care in VA with no evidence of combination antiretroviral therapy (cART) use at care entry, of whom 705 (8.3%) were rural. OUTCOME MEASURE: All-cause mortality. RESULTS: At care entry, rural persons were less likely than urban persons to have drug use problems (10.6% vs. 19.5%, P < 0.001) or hepatitis C (34.3% vs. 41.2%, P = 0.001), but had more advanced HIV infection (median CD4: 186 vs. 246, P < 0.001). By 2 years after care entry, 5874 persons had initiated cART (528 rural [74.9%] and 5346 urban [68.7%], P = 0.001), and there were 1022 deaths (108 rural [15.3%] and 914 urban [11.7%], P = 0.004). The mortality hazard ratio for rural persons compared with urban was 1.34 (95% confidence interval: 1.05-1.69). The hazard ratio decreased to 1.18 (95% confidence interval: 0.93-1.50) after adjustment for HIV severity (CD4 and AIDS-defining illnesses) at care entry, and was 1.17 (95% confidence interval: 0.92-1.50) in a model adjusting for age, HIV severity at care entry, substance use, hepatitis B or C diagnoses, and cART initiation. CONCLUSIONS: Later entry into care drives increased mortality for rural compared with urban veterans with HIV. Future studies should explore the person, care system, and community-level determinants of late care entry for rural persons with HIV.
CONTEXT: Rural persons with human immunodeficiency virus (HIV) face many barriers to care, but little is known about rural-urban variation in HIV outcomes. OBJECTIVE: To determine the association between rural residence and HIV outcomes. DESIGN, SETTING, AND PATIENTS: Retrospective cohort study of mortality among persons initiating HIV care in Veterans Administration (VA) during 1998-2006, with mortality follow-up through 2008. Rural residence was determined using Rural Urban Commuting Area codes. We identified 8489 persons initiating HIV care in VA with no evidence of combination antiretroviral therapy (cART) use at care entry, of whom 705 (8.3%) were rural. OUTCOME MEASURE: All-cause mortality. RESULTS: At care entry, rural persons were less likely than urban persons to have drug use problems (10.6% vs. 19.5%, P < 0.001) or hepatitis C (34.3% vs. 41.2%, P = 0.001), but had more advanced HIV infection (median CD4: 186 vs. 246, P < 0.001). By 2 years after care entry, 5874 persons had initiated cART (528 rural [74.9%] and 5346 urban [68.7%], P = 0.001), and there were 1022 deaths (108 rural [15.3%] and 914 urban [11.7%], P = 0.004). The mortality hazard ratio for rural persons compared with urban was 1.34 (95% confidence interval: 1.05-1.69). The hazard ratio decreased to 1.18 (95% confidence interval: 0.93-1.50) after adjustment for HIV severity (CD4 and AIDS-defining illnesses) at care entry, and was 1.17 (95% confidence interval: 0.92-1.50) in a model adjusting for age, HIV severity at care entry, substance use, hepatitis B or C diagnoses, and cART initiation. CONCLUSIONS: Later entry into care drives increased mortality for rural compared with urban veterans with HIV. Future studies should explore the person, care system, and community-level determinants of late care entry for rural persons with HIV.
Authors: S E Cohn; M L Berk; S H Berry; N Duan; M R Frankel; J D Klein; M M McKinney; A Rastegar; S Smith; M F Shapiro; S A Bozzette Journal: J Acquir Immune Defic Syndr Date: 2001-12-01 Impact factor: 3.731
Authors: Amy C Justice; Elaine Lasky; Kathleen A McGinnis; Melissa Skanderson; Joseph Conigliaro; Shawn L Fultz; Kristina Crothers; Linda Rabeneck; Maria Rodriguez-Barradas; Sharon B Weissman; Kendall Bryant Journal: Med Care Date: 2006-08 Impact factor: 2.983
Authors: Claudia L Schur; Marc L Berk; Jennifer R Dunbar; Martin F Shapiro; Susan E Cohn; Samuel A Bozzette Journal: J Rural Health Date: 2002 Impact factor: 4.333
Authors: Timothy Lahey; Michelle Lin; Bryan Marsh; Jim Curtin; Kim Wood; Betsy Eccles; C Fordham von Reyn Journal: AIDS Res Hum Retroviruses Date: 2007-05 Impact factor: 2.205
Authors: Brettania L W Lopes; Joseph J Eron; Michael J Mugavero; William C Miller; Sonia Napravnik Journal: J Acquir Immune Defic Syndr Date: 2017-10-01 Impact factor: 3.731
Authors: Brian R Wood; Christopher Bell; Jason Carr; Richard Aleshire; Christopher B Behrens; Shelia B Dunaway; Javeed A Shah; Ruanne V Barnabas; Margaret L Green; Christian B Ramers; Pegi L Fina; H Nina Kim; Robert D Harrington Journal: AIDS Care Date: 2018-05-31
Authors: John Weiser; Linda Beer; Brady T West; Christopher C Duke; Garrett W Gremel; Jacek Skarbinski Journal: Clin Infect Dis Date: 2016-06-29 Impact factor: 9.079
Authors: Asher J Schranz; Jessica Barrett; Christopher B Hurt; Carlos Malvestutto; William C Miller Journal: Curr HIV/AIDS Rep Date: 2018-06 Impact factor: 5.071
Authors: Kara M Bensley; John Fortney; Gary Chan; Julia C Dombrowski; India Ornelas; Anna D Rubinsky; Gwen T Lapham; Joseph E Glass; Emily C Williams Journal: J Rural Health Date: 2019-01-31 Impact factor: 4.333
Authors: Candice K Kwan; Charles E Rose; John T Brooks; Gary Marks; Catlainn Sionean Journal: Public Health Rep Date: 2016 Mar-Apr Impact factor: 2.792